Literature DB >> 19018247

Type-dependent oxidative damage in frontotemporal lobar degeneration: cortical astrocytes are targets of oxidative damage.

Anna Martínez1, Margarita Carmona, Manuel Portero-Otin, Alba Naudí, Reinald Pamplona, Isidre Ferrer.   

Abstract

Oxidative injury and stress responses are common features of many neurodegenerative diseases. To assess oxidative stress responses in frontotemporal lobar degeneration (FTLD), we identified increased 4-hydroxynonenal (HNE) adducts using gel electrophoresis and Western blotting in frontal cortex samples in 6 of 6 cases of FTLD with the P301L mutation in the tau gene (FTLD-tau), in 3 of 10 cases with tau-negative ubiquitin-immunoreactive inclusions, and in 2 of 3 cases associated with motor neuron disease. Selectively increased lipoxidation-derived protein damage associated with altered membrane unsaturation and fatty acid profiles was verified by mass spectrometry in FTLD-tau and FTLD associated with motor neuron disease. All FTLD-tau and most cases with increased HNE-positive bands had marked astrocytosis as determined by glial fibrillary acidic protein (GFAP) immunohistochemistry and increased GFAP expression on Western blotting; 2 FTLD cases with tau-negative ubiquitin-immunoreactive inclusions and with increased GFAP expression did not have increased HNE adducts. Bidimensional gel electrophoresis, Western blotting, in-gel digestion, and mass spectrometry identified GFAP as a major target of lipoxidation in all positive cases; confocal microscopy revealed colocalization of HNE and GFAP in cortical astrocytes, superoxide dismutase 1 in astrocytes, and superoxide dismutase 2 in astrocytes and neurons in all FTLD types. Thus, in FTLD, there is variable disease-dependent oxidative damage that is prominent in FTLD-tau, astrocytes are targets of oxidative damage, and GFAP is a target of lipoxidation. Astrocytes are, therefore, crucial elements of oxidative stress responses in FTLD.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19018247     DOI: 10.1097/NEN.0b013e31818e06f3

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  20 in total

1.  Traumatically injured astrocytes release a proteomic signature modulated by STAT3-dependent cell survival.

Authors:  Jaclynn Levine; Eunice Kwon; Pablo Paez; Weihong Yan; Gregg Czerwieniec; Joseph A Loo; Michael V Sofroniew; Ina-Beate Wanner
Journal:  Glia       Date:  2015-12-19       Impact factor: 7.452

2.  Relative stabilities of wild-type and mutant glial fibrillary acidic protein in patients with Alexander disease.

Authors:  Michael R Heaven; Landon Wilson; Stephen Barnes; Michael Brenner
Journal:  J Biol Chem       Date:  2019-09-04       Impact factor: 5.157

3.  Glial fibrillary tangles and JAK/STAT-mediated glial and neuronal cell death in a Drosophila model of glial tauopathy.

Authors:  Kenneth J Colodner; Mel B Feany
Journal:  J Neurosci       Date:  2010-12-01       Impact factor: 6.167

4.  New astroglial injury-defined biomarkers for neurotrauma assessment.

Authors:  Julia Halford; Sean Shen; Kyohei Itamura; Jaclynn Levine; Albert C Chong; Gregg Czerwieniec; Thomas C Glenn; David A Hovda; Paul Vespa; Ross Bullock; W Dalton Dietrich; Stefania Mondello; Joseph A Loo; Ina-Beate Wanner
Journal:  J Cereb Blood Flow Metab       Date:  2017-08-17       Impact factor: 6.200

5.  Phosphoproteomic analysis reveals site-specific changes in GFAP and NDRG2 phosphorylation in frontotemporal lobar degeneration.

Authors:  Jeremy H Herskowitz; Nicholas T Seyfried; Duc M Duong; Qiangwei Xia; Howard D Rees; Marla Gearing; Junmin Peng; James J Lah; Allan I Levey
Journal:  J Proteome Res       Date:  2010-10-22       Impact factor: 4.466

Review 6.  A review on shared clinical and molecular mechanisms between bipolar disorder and frontotemporal dementia.

Authors:  Camila Nascimento; Villela Paula Nunes; Roberta Diehl Rodriguez; Leonel Takada; Cláudia Kimie Suemoto; Lea Tenenholz Grinberg; Ricardo Nitrini; Beny Lafer
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2019-04-20       Impact factor: 5.067

7.  LX2343 alleviates cognitive impairments in AD model rats by inhibiting oxidative stress-induced neuronal apoptosis and tauopathy.

Authors:  Xiao-Dan Guo; Guang-Long Sun; Ting-Ting Zhou; Yi-Yang Wang; Xin Xu; Xiao-Fan Shi; Zhi-Yuan Zhu; Vatcharin Rukachaisirikul; Li-Hong Hu; Xu Shen
Journal:  Acta Pharmacol Sin       Date:  2017-06-26       Impact factor: 6.150

Review 8.  Chronic traumatic encephalopathy-integration of canonical traumatic brain injury secondary injury mechanisms with tau pathology.

Authors:  Jacqueline R Kulbe; Edward D Hall
Journal:  Prog Neurobiol       Date:  2017-08-26       Impact factor: 11.685

Review 9.  Hippocampal sclerosis of aging, a prevalent and high-morbidity brain disease.

Authors:  Peter T Nelson; Charles D Smith; Erin L Abner; Bernard J Wilfred; Wang-Xia Wang; Janna H Neltner; Michael Baker; David W Fardo; Richard J Kryscio; Stephen W Scheff; Gregory A Jicha; Kurt A Jellinger; Linda J Van Eldik; Frederick A Schmitt
Journal:  Acta Neuropathol       Date:  2013-07-18       Impact factor: 15.887

Review 10.  Tau Hyperphosphorylation and Oxidative Stress, a Critical Vicious Circle in Neurodegenerative Tauopathies?

Authors:  Seyedeh Maryam Alavi Naini; Nadia Soussi-Yanicostas
Journal:  Oxid Med Cell Longev       Date:  2015-10-20       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.